Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F McDermott

Showing results (561-570 of 567) with videos related to

Pageof 57
Sort By:
You have reached the last page of results.This site can display upto 567 results.
Cell Reports|January 5, 2022
Integrative clinical and molecular characterization of translocation renal cell carcinomaZiad Bakouny, Ananthan Sadagopan, Praful Ravi, et al.
CA: a Cancer Journal for Clinicians|June 16, 2022
An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinomaElshad Hasanov, Debra Nana Yeboa, Mathew D Tucker, et al.
The Lancet. Oncology|June 28, 2024
Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 studyMohamad E Allaf, Se-Eun Kim, Viraj Master, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2025
Tumor-Intrinsic and Microenvironmental Determinants of Impaired Antitumor Immunity in Chromophobe Renal Cell CarcinomaChris Labaki, Eddy Saad, Katrine N Madsen, et al.
CA: a Cancer Journal for Clinicians|December 13, 2025
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancersRana R McKay, Sumanta Pal, Wanling Xie, et al.
Nature Genetics|June 16, 2009
Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune responseGillian I Rice, Jacquelyn Bond, Aruna Asipu, et al.
Nature Communications|February 6, 2021
Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinomaZiad Bakouny, David A Braun, Sachet A Shukla, et al.
Pageof 57

Showing results (561-570 of 567) with videos related to

Sort By:
Pageof 57
You have reached the last page of results.This site can display upto 567 results.
Cell Reports|January 5, 2022
Integrative clinical and molecular characterization of translocation renal cell carcinomaZiad Bakouny, Ananthan Sadagopan, Praful Ravi, et al.
CA: a Cancer Journal for Clinicians|June 16, 2022
An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinomaElshad Hasanov, Debra Nana Yeboa, Mathew D Tucker, et al.
The Lancet. Oncology|June 28, 2024
Perioperative nivolumab versus observation in patients with renal cell carcinoma undergoing nephrectomy (PROSPER ECOG-ACRIN EA8143): an open-label, randomised, phase 3 studyMohamad E Allaf, Se-Eun Kim, Viraj Master, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 2, 2025
Tumor-Intrinsic and Microenvironmental Determinants of Impaired Antitumor Immunity in Chromophobe Renal Cell CarcinomaChris Labaki, Eddy Saad, Katrine N Madsen, et al.
CA: a Cancer Journal for Clinicians|December 13, 2025
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancersRana R McKay, Sumanta Pal, Wanling Xie, et al.
Nature Genetics|June 16, 2009
Mutations involved in Aicardi-Goutières syndrome implicate SAMHD1 as regulator of the innate immune responseGillian I Rice, Jacquelyn Bond, Aruna Asipu, et al.
Nature Communications|February 6, 2021
Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinomaZiad Bakouny, David A Braun, Sachet A Shukla, et al.
Pageof 57